Actively Recruiting
Study of Biomarkers to Help Diagnose Polycystic Ovarian Syndrome in Females Aged 15 to 25
Led by University Hospital Erlangen · Updated on 2024-10-15
380
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to validate newly identified biomarkers to help diagnose Polycystic Ovarian Syndrome PCOS in adolescent and young adult women aged 15 to 25 years. The study focuses on comparing these biomarkers between women diagnosed with PCOS and those without the condition, following criteria from the International Evidence-based Guideline. This observational study is sponsored by University Hospital Erlangen and seeks to improve understanding and identification of PCOS in this population. Participants include females aged 15 to 25 years who either meet the diagnostic criteria for PCOS or do not have the condition. The study involves an initial visit where clinical information and a blood sample are collected to measure relevant serum parameters related to PCOS. Women diagnosed with PCOS during the study will have two follow-up visits one approximately 3 months after diagnosis and another between 6 to 12 months after the first visit to monitor treatment and collect further clinical and serum data. During the study, participants will undergo clinical assessments and blood draws to gather data about their condition and biomarker levels. The main outcome measured is the validation of these new biomarkers at baseline to aid in diagnosing PCOS. Follow-up visits allow researchers to track changes over time in women with PCOS. The total participation period varies depending on diagnosis and follow-up, with visits spaced over several months to support thorough evaluation and monitoring.
CONDITIONS
Brief Title
Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
Research Team
L
Laura Lotz, Dr. med.
R
Ralf Dittrich, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here